Linsey buys HCP 41.85: Zacks Reiterates Neutral Rating for DaVita HealthCare Partners (DVA)
DaVita HealthCare Partners (NYSE:DVA)âs stock had its âneutralâ rating reiterated ... Estimate and declined year over year on account of poor performance by the HCP segment. The HealthCare Partners segment is further expected to be a drag in 2014 ... ...
42 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home